Risk adjustment: Where are we now?

被引:0
|
作者
Newhouse, JP [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Div Hlth Policy Res & Educ, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Risk adjustment is intended to minimize selection of patients or enrollees in health plans. Current efforts generally are recognized as inadequate, but improvement is difficult. The greatest short-term gain will come from introducing diagnostic information, though outpatient diagnosis data are unreliable. Initial efforts may use inpatient data, but this creates incentives to hospitalize people. Even exploiting diagnosis information leaves substantial imperfections. Partial capitation, common in behavioral health, reduces incentives to select patients and stint on services, but current policy resists it, perhaps because policymakers misinterpret the lesson of the prospective Payment System. Theoretically, not paying plans more for providing additional services is optimal only if consumers are well informed.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 50 条
  • [1] Suicide risk assessment: where are we now?
    Gordon, Michael S.
    Melvin, Glenn A.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (08) : 534 - 534
  • [2] Suicide risk assessment: where are we now?
    Ryan, Christopher J.
    Large, Matthew M.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2013, 198 (09) : 462 - 463
  • [3] Facing the Wildfire Spread Risk Challenge: Where Are We Now and Where Are We Going?
    Sun, Jingjing
    Qi, Wenwen
    Huang, Yuandong
    Xu, Chong
    Yang, Wentao
    [J]. FIRE-SWITZERLAND, 2023, 6 (06):
  • [4] WHERE WERE WE AND WHERE ARE WE NOW
    VERKADE, JG
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 49 - CHED
  • [5] WHERE ARE WE NOW AND WHERE ARE WE GOING
    KARLAN, BY
    [J]. GYNECOLOGIC ONCOLOGY, 1995, 59 (03) : 315 - 317
  • [6] Where Are We Now and Where Are We Going?
    Sempokuya, Tomoki
    McDonald, Nicholas
    [J]. ACG CASE REPORTS JOURNAL, 2023, 10 (05)
  • [7] Bisphosphonates and oesophageal cancer risk: Where are we now?
    Rozenberg, Serge
    Dutton, Susan
    [J]. MATURITAS, 2011, 68 (02) : 106 - 108
  • [8] Sleep apnoea and cancer risk: Where are we now?
    Justeau, Gregoire
    Gagnadoux, Frederic
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2022, 81
  • [9] Where Are We Now With Bilirubin as a Marker of Vascular Risk?
    Breimer, Lars H.
    [J]. ANGIOLOGY, 2014, 65 (03) : 177 - 179